Despite pharma's pandemic push, consumer trust in the industry still comes down to costs: study

Turns out it’s going to take more than a successful vaccine response to a global pandemic to make Americans trust pharma companies.

A new study from Accenture shows a boomerang back to a familiar topic—drug costs.

“We asked what would increase trust in the pharmaceutical industry, and for many people there’s a clear link between cost and trust,” Brad Michel, managing director and life sciences lead at Accenture in North America, said.